Found: 41
Select item for more details and to access through your institution.
Cover Image, Volume 20, Issue 3.
- Published in:
- 2018
- By:
- Publication type:
- Cover Art
Na<sup>+</sup>/H<sup>+</sup> exchanger 3 blockade ameliorates type 2 diabetes mellitus via inhibition of sodium‐glucose co‐transporter 1‐mediated glucose absorption in the small intestine.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 709, doi. 10.1111/dom.13151
- By:
- Publication type:
- Article
CORRIGENDUM.
- Published in:
- 2018
- Publication type:
- Correction Notice
CORRIGENDUM.
- Published in:
- 2018
- Publication type:
- Correction Notice
In response to: Metformin for the management of peri‐operative hyperglycaemia.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Metformin for the management of peri‐operative hyperglycaemia.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
News and Views.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 756, doi. 10.1111/dom.13227
- By:
- Publication type:
- Article
Cannabinoid‐1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 698, doi. 10.1111/dom.13150
- By:
- Publication type:
- Article
A European, multicentre, retrospective, non‐interventional study (EU‐TREAT) of the effectiveness of insulin degludec after switching basal insulin in a population with type 1 or type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 689, doi. 10.1111/dom.13149
- By:
- Publication type:
- Article
A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 681, doi. 10.1111/dom.13148
- By:
- Publication type:
- Article
All‐cause and diabetes‐related healthcare costs among US adults with type 2 diabetes initiating exenatide once weekly or insulin glargine.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 672, doi. 10.1111/dom.13145
- By:
- Publication type:
- Article
Recent trends in the prevalence of type 2 diabetes and the association with abdominal obesity lead to growing health disparities in the USA: An analysis of the NHANES surveys from 1999 to 2014.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 667, doi. 10.1111/dom.13143
- By:
- Publication type:
- Article
Insulin resistance and cardiovascular outcomes in the ORIGIN trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 564, doi. 10.1111/dom.13112
- By:
- Publication type:
- Article
Semi‐physiological model of postprandial triglyceride response in lean, obese and very obese individuals after a high‐fat meal.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 660, doi. 10.1111/dom.13138
- By:
- Publication type:
- Article
Effects of common cold and concomitant administration of nasal decongestant on the pharmacokinetics and pharmacodynamics of nasal glucagon in otherwise healthy participants: A randomized clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 646, doi. 10.1111/dom.13134
- By:
- Publication type:
- Article
Treatment satisfaction with ITCA 650, a novel drug‐device delivering continuous exenatide, versus twice‐daily injections of exenatide in type 2 diabetics using metformin.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 638, doi. 10.1111/dom.13133
- By:
- Publication type:
- Article
Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 629, doi. 10.1111/dom.13127
- By:
- Publication type:
- Article
Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 479, doi. 10.1111/dom.13126
- By:
- Publication type:
- Article
High‐sensitivity C‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 654, doi. 10.1111/dom.13136
- By:
- Publication type:
- Article
Preoperative weight loss with glucagon‐like peptide‐1 receptor agonist treatment predicts greater weight loss achieved by the combination of medical weight management and bariatric surgery in patients with type 2 diabetes: A longitudinal analysis
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 745, doi. 10.1111/dom.13131
- By:
- Publication type:
- Article
Liraglutide and cardiovascular outcomes in adults with overweight or obesity: A <italic>post hoc</italic> analysis from SCALE randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 734, doi. 10.1111/dom.13125
- By:
- Publication type:
- Article
Identification of barriers to insulin therapy and approaches to overcoming them.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 488, doi. 10.1111/dom.13132
- By:
- Publication type:
- Article
Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular risk factors: A narrative review of head‐to‐head comparisons.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 508, doi. 10.1111/dom.13128
- By:
- Publication type:
- Article
Dipeptidyl peptidase‐4 inhibitors moderate the risk of genitourinary tract infections associated with sodium‐glucose co‐transporter‐2 inhibitors.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 740, doi. 10.1111/dom.13130
- By:
- Publication type:
- Article
Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 620, doi. 10.1111/dom.13124
- By:
- Publication type:
- Article
Non‐ST‐elevation myocardial infarction outcomes in patients with type 2 diabetes with non‐obstructive coronary artery stenosis: Effects of incretin treatment.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 723, doi. 10.1111/dom.13122
- By:
- Publication type:
- Article
Different intervention strategies for preventing type 2 diabetes mellitus in China: A systematic review and network meta‐analysis of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 718, doi. 10.1111/dom.13121
- By:
- Publication type:
- Article
Semaglutide improves postprandial glucose and lipid metabolism, and delays first‐hour gastric emptying in subjects with obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 610, doi. 10.1111/dom.13120
- By:
- Publication type:
- Article
Islet neuropeptide Y receptors are functionally conserved and novel targets for the preservation of beta‐cell mass.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 599, doi. 10.1111/dom.13119
- By:
- Publication type:
- Article
Metformin and β‐cell function in insulin‐treated patients with type 2 diabetes: A randomized placebo‐controlled 4.3‐year trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 730, doi. 10.1111/dom.13123
- By:
- Publication type:
- Article
Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study, a multicentre, randomized, double‐blind, active‐controlled, phase 3 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 590, doi. 10.1111/dom.13117
- By:
- Publication type:
- Article
Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo‐controlled randomized study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 530, doi. 10.1111/dom.13116
- By:
- Publication type:
- Article
Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1‐year patient‐level meta‐analysis of the EDITION clinical studies in people with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 541, doi. 10.1111/dom.13105
- By:
- Publication type:
- Article
Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium‐glucose co‐transporter‐2 inhibitors in the USA: A retrospective cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 582, doi. 10.1111/dom.13115
- By:
- Publication type:
- Article
Peri‐operative continuation of metformin does not improve glycaemic control in patients with type 2 diabetes: A randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 749, doi. 10.1111/dom.13118
- By:
- Publication type:
- Article
Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 556, doi. 10.1111/dom.13110
- By:
- Publication type:
- Article
Performance of individually measured vs population‐based C‐peptide kinetics to assess β‐cell function in the presence and absence of acute insulin resistance.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 549, doi. 10.1111/dom.13106
- By:
- Publication type:
- Article
Initiating therapy in patients newly diagnosed with type 2 diabetes: Combination therapy vs a stepwise approach.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 497, doi. 10.1111/dom.13108
- By:
- Publication type:
- Article
Sitagliptin and Roux‐en‐Y gastric bypass modulate insulin secretion via regulation of intra‐islet PYY.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 571, doi. 10.1111/dom.13113
- By:
- Publication type:
- Article
Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET).
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 520, doi. 10.1111/dom.13103
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 477, doi. 10.1111/dom.13091
- Publication type:
- Article